Both in Pharmaceuticals
Annexon vs Alto Neuroscience
Over the past year ANNX returned +40.6% and ANRO returned +107.5%; their daily moves had a correlation of 0.35.
ANNX +40.6% ANRO +107.5%Growth of $1, one year, split-adjusted
| Metric | ANNX | ANRO |
|---|---|---|
| Price | $4.33 | $23.30 |
| Market cap | $820.9M | $914.3M |
| Today | +3.34% | +2.64% |
| 1 month | +7.4% | −1.6% |
| 6 months | −24.0% | −4.9% |
| Year to date | −13.7% | +30.9% |
| 1 year | +36.6% | +91.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $209.2M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 64.2% | 56.5% |
| Short % of float | 20.6% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).